Category: Stock Market

The Aussie Broadband Ltd (ASX: ABB) share price fell as the Over The Wire Holdings Ltd (ASX: OTW) share price surged after the parties moved closer to a merger.

The companies entered into a Scheme Implementation Deed that will allow Aussie Broadband to buy 100% of OTW.

The implied offer price that the bidder is paying is $5.75 per OTW share. Shareholders in the target can opt to receive the payment in all cash, all scrip or a combination.

Aussie Broadband share price sinks as OTW share price rises

The Aussie Broadband share price tumbled 5.5% to $5.15 during lunch time trade. In contrast, the OTW share price jumped 5.6% to $5.70.

Given how close the OTW share price is trading to the offer price, the market believes the deal will go through.

This isn’t a done deal, but the OTW board is recommending its shareholders vote in favour of the merger. The board’s support is conditioned on a favourable independent expert report and assumes no other bidder lobs a better deal.

Financial outcomes from the merger

It is anticipated that the merged entity will deliver annual synergies of between $8 and $12 million within three years.

Other benefits touted by Aussie Broadband are ongoing capital expenditure savings and the ability to enhance skills, products and solution capabilities for the group.

Further, the acquisition is expected to be earnings per share (EPS) accretive on a pre- and post-synergy proforma statutory FY21 basis.

The proforma statutory FY21 revenue for the combined group is estimated to be $463.1 million. The earnings before interest, tax, depreciation and amortisation (EBITDA) is pegged at $51 to $55 million, inclusive of run-rate synergies.

Rational for the acquisition

OTW offers telecoms and IT solutions to businesses while Aussie Broadband largely sells NBN broadband connections.

The bidder is capitalising on the high Aussie Broadband share price, which has rallied 157% this year.

JPMorgan reckons the takeover will give Aussie Broadband a nice earnings boost, although mergers and acquisitions (M&As) carry risks.

Is the deal good for the Aussie Broadband share price?

“We estimate the proposal would be highly EPS accretive largely because of ABB’s under-geared balance sheet,” said JPMorgan.

“However, we also see up to 7% value dilution depending on the level of equity included in the acquisition.

“Further, while ABB still has little to no debt, there could be further acquisition-led growth which represents a risk, in our view.”

Nonetheless, the broker is recommending the Aussie Broadband share price as “overweight”. Its 12-month price target on the shares is $6.50.

The post Aussie Broadband (ASX:ABB) share price slumps as it closes in on OTW appeared first on The Motley Fool Australia.

More reading

• Why is the Aussie Broadband (ASX:ABB) share price soaring today?
• Why did the Aussie Broadband (ASX:ABB) share price speed 7% higher today?

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Aussie Broadband Limited and Over The Wire Holdings Ltd. The Motley Fool Australia has recommended Aussie Broadband Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/31lsRIq

The S&P/ASX 200 Health Care index (ASX: XHJ) pared its October gains in November. The index went from 2.62% up in October to a slight 0.11% fall over November to 46,299 points.

However, ASX healthcare shares did outperform the S&P/ASX 200 Index (ASX: XJO) which fell 1.56% over November as the market continued to grapple with the latest COVID-19 reopening challenges.

Despite the weakness of the broad healthcare sector last month, several companies pushed well ahead of the pack.

Here are the top 5 performing ASX healthcare shares for November.

Sonic Healthcare Limited (ASX: SHL)

After a poor start to the month, shares in ASX healthcare giant Sonic Healthcare finished the month 7% in the green.

Early in November, Sonic’s share price took a nosedive and sunk to a 2-month low of $38.51.

However, investors began piling back into Sonic after it released its Q1 FY22 trading update. In the release, the company revealed revenue growth of 5% year-on-year (YoY) to $3.08 billion and EBITDA came in 16% higher.

Robust demand for Covid-19 tests and vaccinations bumped the company’s sales and earnings during the quarter. These trends look set to continue into CY22, according to expert commentary.

These figures were a positive surprise for the market, as many analysts were banking on Sonic’s revenue declining in FY22.

As such, investors bought in at the lows and drove the Sonic share price north to finish the month at $42.70.

Pro Medicus Limited (ASX: PME)

Pro Medicus shares started catching bids in late October and the momentum continued for the next few weeks. The company finished 17% in the green last month after its share price charged north with authority from the get-go.

Investors appeared to view Pro Medicus’ annual report in a positive light. The company reiterated its FY21 earnings results in more detail. It was a successful period and the company secured multiple contract wins during the year.

As a result, 9 out of the 20 leading hospitals in the US are now using the Pro Medicus Visage-7 imaging platform.

Pro Medicus anticipates it will secure additional contracts in FY22 and will continue rolling out its Visage RIS platform. In addition, cash flow from several contracts already secured is set to be realised this coming year. The company expects that this will drive growth at its top and bottom lines.

After shooting off a low of $53.28 on 1 November, Pro Medicus shares finished the month at $62.48. This netted shareholders a tidy $9.20 per share profit for the month.

Incannex Healthcare Ltd (ASX: IHL)

Shares in the medicinal cannabinoid company gained 41% in November.

A slew of positive catalysts bolstered the Incannex share price — mainly clinical trial approvals and the company’s quarterly activities report released in late October.

For example, an ethics committee has approved its Phase 2a clinical trial examining the safety and efficacy of psilocybin in primary anxiety disorder.

Psychedelics like psilocybin are gaining traction within medicinal circles as a front-line treatment for many mental illnesses. This is largely due to their non-invasive nature and excellent treatment results.

In its activities report, Incannex told the ASX it has successfully raised $17.66 million from an option exercise program.

Investors piled into the company after these updates and sent its share price soaring from a low of 40.5 cents to 57 cents at the closing bell on 30 November.

SDI Limited (ASX: SDI)

Shares in SDI, a supplier of dental restoration materials, gained 10% during November. This netted shareholders a 10 cents per share gain.

Investors responded positively to SDI’s AGM mid-month, where the company gave a high-level view of its operations across the financial year.

SDI noted it had paid total dividends of 3.15 cents per share last year, up 70% on the prior corresponding period.

SDI also highlighted several product launches in its whitening and glass ionomer division and said it is focused on investing in research and development.

After a jagged start to the month, the SDI share price took off from $1.01 on 12 November to finish the month at $1.10.

In the past 12 months, SDI shareholders have enjoyed a 37% return to date.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

Despite it being a quiet month on the news front, shares in Fisher & Paykel still climbed 8% during November.

Fisher & Paykel shares traded as low as $29.42 early on in the month before going as high as $32.30 at the close on 25 November. Investors then sold off their positions and the share price finished the month at $31.58.

One key takeout for the period was the company’s half-year results released on 25 November. Fisher & Paykel outlined it had suffered a slight down-step in revenue and earnings due to pressures on hospitals and patient turnover from the pandemic.

Despite this, consumables revenue came in 8% higher and formed the bolus of total sales. The company’s home care division also grew during the first half.

Despite the share price growth in November, it’s been a challenging year for Fisher & Paykal investors. Their positions are down almost 5% since this time last year.

The post These were the 5 best performing ASX healthcare shares in November appeared first on The Motley Fool Australia.

More reading

• 3 hot ASX shares to buy right now: advisor
• ASX 200 (ASX:XJO) midday update: ANZ hit with class action, GUD sinks
• Advisor reveals the 3 most popular ASX shares among his clients
• ASX 200 healthcare shares jump amid Omicron fears
• Why a leading broker is bullish on these 3 ASX shares

The author has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended SDI Limited and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/31oX8Gt

The Appen Ltd (ASX: APX) share price is under pressure again on Thursday.

In afternoon trade, the artificial intelligence data services company’s shares are down 3.5% to $9.47.

This means the Appen share price is now down 14% since this time last week and 63% in 2021.

Where next for the Appen share price?

Where the Appen share price goes next is very difficult to say. In fact, the broker community is incredibly divided on the matter.

In the bear corner, there is the team at Macquarie Group Ltd (ASX: MQG). Last week its analysts downgraded the company’s shares to an underperform rating and slashed the price target on them by ~20% to $9.50.

Its analysts have been speaking to industry contacts and believe structural shifts could be impacting demand for Appen’s services.

Macquarie understand that many big tech companies are now bypassing Appen and other third-party data annotation service providers due to tighter privacy and data retention standards. This has led to tech companies developing their own crowd-sourcing solutions for data annotation.

The broker feels this will lessen demand for Appen’s services and suspects it could fall short of the market’s expectations and its own guidance.

What about the bulls?

The team at Citi remain positive on the Appen share price and have a buy rating and $17.10 price target on it.

This price target implies potential upside of approximately 80% for its shares over the next 12 months.

While the broker notes that Appen will need a strong second half to achieve its full year guidance, it was pleased to see increased traffic to Google and Facebook’s sites in October. Citi feels this bodes well for data annotation demand. This is further supported by a strong third quarter update from industry rival Telus International last month.

Which broker makes the right call, only time will tell. But investors may not need to wait long. Appen released a trading update during the second week of December last year. This would mean an update is imminent if it chooses to do the same again this year.

The post Why are brokers so divided on the Appen (ASX:APX) share price? appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX shares to sell next week
• These were the worst performing ASX 200 shares last week
• Appen (ASX:APX) share price smashed after broker downgrade
• Own Appen (ASX:APX) shares? Here’s why this $US60b fund just bought a 5% stake
• 2 ASX 200 tech shares Citi rates as buys

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3EfyOoZ

Buying up ASX travel shares amid the initial COVID-19 panic in March 2020 served those investors pretty well.

So with the same mindset, one could repeat and rinse during the current Omicron-induced ASX dip.

Shaw and Partners portfolio manager James Gerrish, writing in his newsletter Market Matters (MM), certainly thinks so.

“MM believes it’s time to start considering the out of favour travel and tourism stocks,” he said. 

“Don’t forget how quickly things have changed through 2021!”

Here are 3 ASX shares Gerrish suggested considering:

ASX travel shares are on sale right now

In order of preference, Gerrish likes the look of Corporate Travel Management Ltd (ASX: CTD), Webjet Limited (ASX: WEB) and Flight Centre Travel Group Ltd (ASX: FLT)

“But it depends on price and risk appetite, with the last 2 likely to have more upside potential,” he said.

“That is, less capital required for the same result.”

All 3 are undoubtedly selling at a discount at the moment.

Over the past month, Corporate Travel shares have lost around 15%, Webjet has sunk 18%, and Flight Centre dived almost 15%.

Corporate Travel shares on Thursday morning were going for $21.32. Gerrish would pounce if it dipped below the $20 mark.

Webjet has been discounted close to 24% since it hit a 52-week high early last month.

“Omicron [is] clearly causing acceleration towards the downside,” said Gerrish.

“We like Webjet under $5 but I would leave some ammunition to average under $4.50 if the virus outlook deteriorates further.”

Flight Centre shares lost another 1.78% on Thursday morning to trade at $17.11. Its 52-week high of $25.28 in October now seems like a distant memory.

“As we saw from the 85% rally from its August low, the stock’s good value into current weakness when we can finally start packing our bags,” said Gerrish.

“I have planned a quick trip up to Hamilton mid next year but I didn’t consider anything overseas. I imagine many people are the same … looking at how little accommodation is left domestically.”

He added that the Flight Centre share price could drop another 10% to 20%, but it would eventually rise again.

“I do believe it will be well above $20 at some stage in 2022,” Gerrish said.

“The risk-reward is becoming appealing.”

The post 3 ASX travel shares to buy while Omicron scares everyone appeared first on The Motley Fool Australia.

More reading

• Why did the Flight Centre (ASX:FLT) share price go backwards in November?
• Why is the Webjet (ASX:WEB) share price taking off 5% today?
• How did ASX 200 travel shares weather the Omicron storm today?
• Why EML Payments, Pact, Senex, and Webjet shares are dropping
• Flight Centre (ASX:FLT) share price partially recovers as boss calls for calm

Motley Fool contributor Tony Yoo owns shares of Corporate Travel Management Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management Limited, Flight Centre Travel Group Limited, and Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3ocAmKB

The Altech Chemicals Ltd (ASX: ATC) share price is having a day to forget today. This comes after the alumina producer announced an update on its recent share placement.

During mid-afternoon trade, Altech Chemicals shares are down 14.29% to 12 cents apiece. In comparison, the All Ordinaries (ASX: XAO) is 0.78% lower to 7,498.9 points.

What’s dragging Altech Chemicals shares lower?

Investors are scrambling to sell the Altech Chemicals share price as the company prepares to dilute existing shareholder value.

According to its release, Altech Chemicals advised it has successfully completed an $8.1 million share placement.

The offer received strong support from an array of investors, picking up Altech Chemicals shares at 10.7 cents each. This represented a 24% discount to the last closing price of 14 cents apiece on 29 November.

In addition, the company will undertake a share purchase plan (SPP) whereby existing shareholders can apply. The terms and conditions of the offer are the same as the placement.

The shares will be issued in a single tranche under the company’s listing rule 7.1. In total, 76 million shares will be created and allotted to investor accounts on 23 December.

Proceeds of the placement will be used to accelerate the construction of a battery materials coating pilot plant in Germany. Altech Chemicals is funding 75% of the costs to build the facility.

Furthermore, the remaining monies will be allocated towards a number of smaller initiatives. This includes purchasing land at the Schwarze Pumpe Industrial Park, completing the preliminary feasibility study, and commencing a definitive feasibility study.

About the Altech Chemicals share price

Since this time last year, Altech Chemicals shares have posted a gain of 200%, reflecting positive investor sentiment. The company’s share price reached a multi-year high of 15 cents late last month.

On valuation grounds, Altech Chemicals commands a market capitalisation of around $154.70 million, with 1.29 billion shares on issue.

The post Here’s why the Altech Chemicals (ASX:ATC) share price is plunging 14% today appeared first on The Motley Fool Australia.

More reading

• 3 ASX travel shares to buy while Omicron scares everyone
• Why API, Chalice Mining, GUD, and Worley shares are charging higher
• Are these 2 ASX dividend shares buys in December 2021?
• Jadar Resources (ASX:JDR) share price rockets 24% on new lithium deal
• Is Square stock a buy?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3dqL36t

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.4% to 7,206.7 points.

Four ASX shares that are not letting that hold them back are listed below. Here’s why they are charging higher:

Australian Pharmaceutical Industries Ltd (ASX: API)

The API share price has jumped 17% to $1.75. This follows news that Woolworths Group Ltd (ASX: WOW) has outbid rival Wesfarmers Ltd (ASX: WES) for the pharmacy chain operator. Woolworths has made a $1.75 cash per share offer, which represents a 20 cents per share or 12.9% increase over Wesfarmers’ offer. Judging by the share price reaction, it appears as though investors believe Wesfarmers will come back with an improved offer.

Chalice Mining Ltd (ASX: CHN)

The Chalice Mining share price is up 2% to $9.57. This morning the mineral exploration company revealed that a new shallow high-grade PGE-Ni-Cu-Co sulphide discovery has been made at Chalice-owned farmland within the 100%-owned Julimar Project. This is a significant discovery as the new zone is located immediately south of the ~6.5km long Hartog AEM anomaly.

GUD Holdings Limited (ASX: GUD)

The GUD share price is up over 2.5% to $11.07. Investors have been buying the diversified products company’s shares following the release of a broker note out of Citi. According to the note, the broker has retained its buy rating and lifted its price target on the company’s shares to $15.70. This follows the announcement of its acquisition of Auto Pacific Group for approximately $744.6 million.

Worley Ltd (ASX: WOR)

The Worley share price is up 3.5% to $9.83. This appears to have been driven by a bullish broker note out of Morgan Stanley this morning. According to the note, its analysts have upgraded the engineering company’s shares to an overweight rating with an improved price target of $12.00. The broker expects Worley to benefit from the clean energy transition.

The post Why API, Chalice Mining, GUD, and Worley shares are charging higher appeared first on The Motley Fool Australia.

More reading

• Here’s why the Chalice Mining (ASX:CHN) share price is glowing today
• ASX 200 (ASX:XJO) midday update: Afterpay sinks, Woolworths bids for API
• These were the 5 best performing ASX shares in November
• API (ASX:API) share price rockets 16% higher after Woolworths launches takeover approach
• Woolworths (ASX:WOW) share price falls after outbidding Wesfarmers for API

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3Ifsyjh

December 2021 could be a good time of year to find ASX dividend shares to boost investment income.

Businesses that are expected to pay high dividend yields may be attractive for people wanting to beat what they get from the bank.

With that in mind, these two could fit the bill:

Adairs Ltd (ASX: ADH)

Adairs is currently rated as a buy by the broker Morgans, with a price target of $4.80 – that’s 35% higher than where it is right now. The broker likes the opportunities presented by the Focus acquisition and believes that Adairs looks good value based on its earnings potential and expected dividend income.

Morgans puts the current Adairs share price at just 8x FY23’s estimated earnings with a potential grossed-up dividend yield of 11.8%.

Looking at the ASX dividend share’s completed acquisition of Focus on Furniture, it’s expected to deliver pro forma double digit accretion to earnings per share (EPS) in FY23, being the first year of ownership. The enterprise value price is $80 million, which compares to FY21 earnings before interest and tax (EBIT) of $32.8 million.

Adairs said that there are growth opportunities from a national store roll out, online growth and category/range expansion. Management said that there is complementary customer product overlap with opportunities to leverage strengths in store expansion, product development and last mile delivery capability.

It has a plan to continue to grow the number of larger stores, which are materially more profitable than smaller format stores.

Pacific Current Group Ltd (ASX: PAC)

This ASX dividend share is currently rated as a buy by the broker Ord Minnett, with a price target of $10.30 – that’s around 50% higher than where it is today.

One of the main reasons why the broker likes this business is the recent listing of GQG Partners Inc. (ASX: GQG). The broker thinks Pacific seems good value.

Looking at the estimates for FY23, Pacific Current is valued at 11x FY23’s estimated earnings with a grossed-up dividend yield of 8.7% for that year.

This business invests in fund managers around the world and helps them grow with expertise and capital

The company’s management fee profitability continues to rise, with growing funds under management (FUM) and a reduction in expenses.

The ASX dividend share continues to look for investment opportunities. It’s expecting continued improvement in corporate and boutique prospects.

It’s expecting continued progress in FY22 and FY23, as well as “strong cash flow” which supports the company’s full year dividend payout in the 60% to 80% range. It’s expecting higher revenue and profit in FY22, as well as broad organic FUM growth across the portfolio.

The business recently outlined that altogether its net asset value at 30 June 2021 was $7.92, and at 17 November 2021 it was $10.46 which included the book value of GQG at the time.

It’s also expecting to access a new credit line and/or dedicated external pools of capital in FY22. The ASX dividend share is also planning to deploy the proceeds of the 1% of GQG it sold with the fund manager’s listing.

The post Are these 2 ASX dividend shares buys in December 2021? appeared first on The Motley Fool Australia.

More reading

• What happened with the Adairs (ASX:ADH) share price today?
• Top ASX shares to buy in December 2021
• Here’s why ASX retail shares are in the spotlight on Tuesday
• Is the Adairs (ASX:ADH) share price a buy following the company’s latest acquisition?
• Leading brokers name 3 ASX shares to buy today

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended ADAIRS FPO. The Motley Fool Australia owns shares of and has recommended ADAIRS FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3xHJXwl

The Jadar Resources Ltd (ASX: JDR) share price is surging in intraday trade, up 24.07% at time of writing.

This gain comes even as the All Ordinaries Index (ASX: XAO) is under pressure, down 0.53%.

Below we look at the lithium partnership announced this morning that looks to be driving ASX investor interest in the junior resource explorer.

What lithium partnership was announced?

The Jadar Resources share price is off to the races after the company reported it has signed a non-binding Memorandum of Understanding (MOU) with Yahua International Investment and Development to acquire and develop lithium projects and supply spodumene concentrates globally.

Yahua is a subsidiary of Chinese listed Sichuan Yahua Industrial Group Co Ltd (SHE: 002497), one of China’s major lithium hydroxide and lithium carbonate producers.

The MOU would see Jadar and Yahua enter into a strategic partnership agreement within 6 months. If that goes through, Jadar will sell 100% of the lithium concentrate from its lithium projects to Yahua.

Yahua also has been offered an equity stake of up to 80 million shares in Jadar for 4.5 cents per share. That’s some 35% below the current Jadar Resources share price of 7 cents. If Yahua opts to invest in shares, the MOU stipulates that Jadar will only use the additional funds to explore for and develop lithium projects.

Commenting on the partnership, Jadar Resources’ executive director, Adrian Paul said:

I am extremely excited to progress this MOU and strategic partnership with Yahua. The EV and lithium markets have seen substantial growth over the past year as global adoption of EV technologies starts to materialise. The MOU provides a potential mechanism for both the development of our current lithium assets as well as an avenue for further growth in the portfolio through acquisition.

Jadar Resources share price snapshot

The Jadar Resources share price is up 168% in 2021. For some context, the All Ords is up 10% year-to-date.

Over the past month, Jadar’s shares have gained 72%.

The post Jadar Resources (ASX:JDR) share price rockets 24% on new lithium deal appeared first on The Motley Fool Australia.

More reading

• Are these 2 ASX dividend shares buys in December 2021?
• Is Square stock a buy?
• The Zip (ASX:Z1P) share price fell 20% in November and now trades at a 52-week low
• Here’s why the Chalice Mining (ASX:CHN) share price is glowing today
• ASX 200 (ASX:XJO) midday update: Afterpay sinks, Woolworths bids for API

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/32T34bp

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Good news for Square (NYSE: SQ) came on Nov. 29 when CEO Jack Dorsey announced he would step down as the CEO of Twitter (NYSE: TWTR). For several years, he has run both Square and Twitter simultaneously.

A full-time focus on Square could enhance the fintech stock’s already-robust growth. The question for investors is whether that makes Square stock a buy now. 

Dorsey’s new focus and Square stock

Most of the news of Dorsey’s departure focused on its effects on Twitter but provided little coverage of how Square might be affected. An initial spike in Square’s stock price on Nov. 29 also dissolved quickly as an intraday high of nearly $221 per share led to a close at $212.87 per share, a gain of 0.4%. 

Despite the tepid reaction, Dorsey’s decision to focus on Square looks like the right call. Since launching its initial public offering (IPO) in late 2013, Twitter stock has experienced a net gain of about 2%. A 75% drop in the middle of the 2010s hampered the long-term performance and resulted in Dorsey’s return to the helm at Twitter. Conversely, Square stock has fared much better, rising more than 1,500% since its 2015 IPO.

More potential to tap

Moreover, Square has nearly reached a $100 billion market cap despite serving only seven countries. This means that it has not entered most of the developed world, let alone the more than 200 countries served by arch-rival PayPal.

Also, it competes with PayPal’s Venmo in the consumer market with its Cash App payments platform. Adding Bitcoin (CRYPTO: BTC) trading capabilities before Venmo enabled cryptocurrency trading also helped boost Cash App. Furthermore, its purchase of AfterPay will bring “buy now, pay later” to both Cash App and its Square ecosystem.

Those consumer-oriented offerings have not changed Square’s business focus as the newly opened Square Bank serves only enterprises, as do functions such as Square Register and Square Payroll. Additionally, its new countries, such as France, have thriving, small-business communities, and this emphasis could expand across the Eurozone as it prepares to enter Spain in early 2022.

The financials and Square stock 

These moves have taken Square’s revenue in the first nine months of the year to $13.6 billion, 114% higher than in the first three quarters of 2020. Nonetheless, since accounting rules force Square to log Bitcoin payment volumes as revenue, actual revenue was closer to $5.7 billion during this time.

Still, net income for the first three quarters came in at $243 million, up from a loss of $81 million in the first nine months of 2020. Limiting the growth of operating expenses during the period to 52% allowed the company to turn an operating profit, leading to a positive net income.

Despite the growth in revenue and earnings, the stock trades at approximately the same level as it did one year ago. Investors sold off the stock in recent weeks as many growth stocks have fallen. Its valuation may cause concerns as the company trades for about 200 times earnings. While the price-to-sales (P/S) ratio stands at just under seven, the stock sells for about 14 times sales when not counting Bitcoin payment volumes.

Despite the turn to profitability, consensus estimates call for earnings growth of only 9% in fiscal 2022. Such a growth slowdown could make its current valuation challenging to justify.

Should you consider Square stock?

The long-term investment thesis for Square remains intact. Jack Dorsey’s new, full-time commitment to Square bodes well for its future. Furthermore, the fact that it can reach a $100 billion market cap with a presence in only seven countries indicates it has only begun to tap its potential.

Nonetheless, investors need to watch the valuation. While Square appears on track to register substantial revenue increases, an earnings-growth slowdown could continue to hamper the stock. While it may not be too late to buy Square stock, it could mean the stock remains stagnant until signs of faster earnings growth begin to appear. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Is Square stock a buy? appeared first on The Motley Fool Australia.

More reading

• Afterpay (ASX:APT) share price slides amid Square takeover delay
• Is the Afterpay (ASX:APT) Square takeover a done deal?
• What is the difference between buying Square and Afterpay (ASX:APT) shares?
• How Afterpay (ASX:APT) is using AI in its push for BNPL domination
• Afterpay (ASX:APT) share price shoots higher as Square vote looms

Will Healy owns shares of Square. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Square. The Motley Fool Australia has recommended PayPal Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/3G2PT5W

It has been another disappointing day for the Zip Co Ltd (ASX: Z1P) share price on Thursday.

In morning trade, the buy now pay later (BNPL) provider’s shares fell over 5% to a new 52-week low of $4.78.

This means the Zip share price is already down almost 8% in December following a 20.5% decline in November.

Why did the Zip share price tumble in November?

The Zip share price tumbled last month despite the company releasing a strong trading update at its annual general meeting.

This weakness could have been driven by concerning reports in the United States which claim that fraud is rising in the BNPL industry.

According to CNBC, experts are saying that criminals are exploiting weaknesses in the application process for BNPL loans and stealing items ranging from pizzas to video game consoles. And while Zip wasn’t mentioned in the report, it still appears to have spooked some Zip shareholders and overshadowed its strong performance in October.

Speaking of which, at its annual general meeting management revealed that its strong total transaction volume (TTV) growth continued in October.

Zip’s Managing Director and CEO, Larry Diamond, commented: “October was Zip’s highest TTV month on record processing over $770m in transaction volume for the month, which was a 94% increase on October 2020, with the Company now annualising at over $9b. Off the back of the rebrand, October delivered a 24% MoM increase which provides outstanding momentum entering the seasonal peak period.”

Is this a buying opportunity?

While the recent pullback in the Zip share price is disappointing for shareholders, it could be a buying opportunity for non-shareholders.

That’s the view of the team at Morgans, which has an add rating and $8.56 price target on its shares. Based on the current Zip share price, this implies potential upside of 79% over the next 12 months.

Morgans commented: “We continue to see longer term upside if Z1P can continue to execute on its ambitions of becoming a global payments player.”

The post The Zip (ASX:Z1P) share price fell 20% in November and now trades at a 52-week low appeared first on The Motley Fool Australia.

More reading

• These were the 5 worst performing ASX 200 shares in November
• These are the 10 most shorted ASX shares
• Down 20% in a month: Is the Zip (ASX:Z1P) share price too cheap to ignore?
• Why Zip (ASX:Z1P) and this ASX tech share could be buys
• Are Zip (ASX:Z1P) shares a buy? Some pros and cons from Motley Fool analyst Kate Lee

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended ZIPCOLTD FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/31lKXde